Department of Molecular Pathology, Faculty of Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-0811, Japan.
J Leukoc Biol. 2010 Jun;87(6):965-75. doi: 10.1189/jlb.1009649. Epub 2010 Jan 20.
Skp derived from Escherichia coli attracts leukocytes as a pure chemotactic ligand of the C5a receptor. We identified the submolecular region of Skp that binds and activates the C5a receptor to be -Gln103-Asp104-Arg105- using synthetic peptide fragments and site-directed mutants of Skp. As the C5a amino acid residue equivalent to Gln103 of Skp is Leu72, we prepared a Gln103Leu-Skp mutant as a recombinant protein. With this mutation, Skp gained secretagogue functions including induction of the respiratory burst and granule release reactions and leukotriene generation, in addition to the chemoattraction displayed by C5a. However, when we substituted Leu72 with Gln in C5a, the L72Q-C5a mutant largely lost its secretagogue function. These functional conversions were reproduced using synthetic peptides mimicking the receptor-binding/-activating regions of the recombinant proteins. Receptor-binding assays using the mimicking peptides demonstrated only a small difference between the Leu72-C5a and Gln72-C5a peptides. Consistently, L72Q-C5a apparently antagonized C5a secretagogue function. These results indicate that the difference between a chemotactic response and a combined chemotactic/secretory response can be attributed not to the nature of the receptor but to guidance by the ligand, at least in the case of C5a receptor-mediated leukocyte responses.
Skp 来源于大肠杆菌,作为 C5a 受体的纯趋化配体吸引白细胞。我们通过合成肽片段和 Skp 的定点突变体鉴定出与 C5a 受体结合并激活的 Skp 的亚分子区域为 -Gln103-Asp104-Arg105-。由于 C5a 的氨基酸残基相当于 Skp 的 Gln103 为亮氨酸 72,我们制备了 Gln103Leu-Skp 突变体作为重组蛋白。通过这种突变,Skp 获得了分泌剂功能,包括诱导呼吸爆发和颗粒释放反应以及白三烯的产生,除了 C5a 显示的趋化性。然而,当我们用亮氨酸取代 C5a 中的亮氨酸 72 时,L72Q-C5a 突变体的大部分分泌剂功能丧失。这些功能转换使用模拟重组蛋白受体结合/激活区域的合成肽重现。使用模拟肽的受体结合测定表明,Leu72-C5a 和 Gln72-C5a 肽之间仅存在微小差异。一致地,L72Q-C5a 显然拮抗 C5a 分泌剂功能。这些结果表明,趋化反应和趋化/分泌联合反应之间的差异不是由于受体的性质,而是由于配体的引导,至少在 C5a 受体介导的白细胞反应中是这样。